CAZANAT 60 mg Tabs. 30 s BT BOTTLE

CAZANAT 60 mg Tabs. 30 s BT BOTTLE Specification

Salt Composition
Cabozantinib 60 mg

Brand Name
CAZANAT

Indication
Thyroid cancer, renal cell carcinoma

Packaging Type
HDPE bottle

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
1 bottle of 30 tablets

Life Span
24 months

Drug Type
Allopathic

Ingredients
Cabozantinib

Physical Form
Tablet

Function
Anti-cancer agent

Recommended For
Thyroid cancer patients

Dosage
60 mg per tablet

Dosage Guidelines
As prescribed by physician

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store in a cool, dry place

Intended Use
Oncology

Prescription Status
Prescription only

Bottle Material
Plastic

Shape
Oval

Blister Presence
No blister

Tablet Markings
CAZ60 imprint

Moisture Protection
Yes

Color
White film-coated

Administration Route
Oral

CAZANAT 60 mg Tabs. 30 s BT BOTTLE Trade Information

Minimum Order Quantity
10 Bottles

Supply Ability
5000 Bottles Per Month

Delivery Time
2-10 Days

About CAZANAT 60 mg Tabs. 30 s BT BOTTLE

Discover CAZANAT 60 mg Tabs-an elite anti-cancer masterpiece formulated for those seeking a champion in oncology therapy. This splendiferous product features Cabozantinib 60 mg, designed exclusively for thyroid cancer and renal cell carcinoma. Each rare white, oval, film-coated tablet is imprinted with 'CAZ60' and housed in a moisture-resistant, HDPE plastic bottle. With an unbeatable price for 30 tablets per bottle, CAZANAT brings you a blend of strength and reliability for adult patients. Trust this allopathic marvel, suitable only by prescription, to redefine cancer management.

Outstanding Features and Versatile Usage of CAZANAT 60 mg Tabs

CAZANAT 60 mg Tabs stand out with advanced moisture protection, ensuring tablet potency throughout their 24-month lifespan. Designed for oral administration, these prescription-only, allopathic tablets provide precision in cancer care. Intended for adults, CAZANAT targets thyroid cancer and renal cell carcinoma, serving as an impeccable addition to oncology treatment regimens. Supplied in a secure HDPE bottle of 30 tablets, these film-coated, oval-shaped tabs guarantee consistent dosage and easy identification, making them the ideal choice for healthcare professionals and patients alike.

Export Markets, Supply, and Delivery of CAZANAT 60 mg Tabs

CAZANAT 60 mg Tabs have a robust presence across main export markets, including Asia, Africa, the Middle East, and Europe. With stock ready for shipment, we offer quick dispatch to meet urgent clinical needs. Our supply ability accommodates both small and large orders efficiently. Interested buyers can request samples as per our flexible sample policy, with competitive asking prices available upon inquiry. Always available for bulk trading, CAZANAT ensures prompt, reliable delivery from India's trusted exporter, supplier, and wholesaler.

FAQ's of CAZANAT 60 mg Tabs. 30 s BT BOTTLE:

Q: How should CAZANAT 60 mg Tablets be stored to maintain their efficacy?

A: Store CAZANAT 60 mg Tablets in a cool, dry place within their HDPE plastic bottle to protect them from moisture and maintain maximum potency.

Q: What is the recommended usage process for CAZANAT 60 mg Tabs in cancer treatment?

A: CAZANAT 60 mg Tabs should be taken orally as prescribed by your physician, typically for the management of thyroid cancer or renal cell carcinoma in adults.

Q: When can I expect delivery upon placing an order for CAZANAT 60 mg Tabs?

A: Orders for CAZANAT 60 mg Tabs are quickly dispatched from ready stock, with delivery times varying based on your location and order size.

Q: Where are CAZANAT 60 mg Tabs exported from, and who can purchase them?

A: CAZANAT 60 mg Tabs are exported from India and are available to licensed medical professionals or wholesalers dealing with oncology therapies.

Q: What benefits do patients gain from choosing CAZANAT 60 mg Tabs for oncology treatment?

A: Patients benefit from CAZANAT's consistent dosage, enhanced moisture protection, and its efficacy as a targeted anti-cancer agent in thyroid cancer and renal cell carcinoma.